ExploreWatchlistsPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Total assets

Immuno-Biological Laboratories Co., Ltd. (4570)

Market cap
¥8.5B
P/E ratio
24.6x
Develops antibody-based diagnostic tools and testing services for medical research, plus manufactures cosmetics using human-type collagen from silkworms.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Mar 31, 20262,155+16.78%
Mar 31, 20251,845+14.01%
Mar 31, 20241,619+12.85%
Mar 31, 20231,434-15.89%
Mar 31, 20221,705-7.22%
Mar 31, 20211,838-22.54%
Mar 31, 20202,373-20.59%
Mar 31, 20192,988-9.31%
Mar 31, 20183,295-3.82%
Mar 31, 20173,426+2.07%
Mar 31, 20163,356+6.96%
Mar 31, 20153,138

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat